NYMX
Price:
$0.1999
Market Cap:
$6.33M
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physician...[Read more]
Industry
Biotechnology
IPO Date
1997-11-26
Stock Exchange
NASDAQ
Ticker
NYMX
According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.86. This represents a change of -44.42% compared to the average of -5.14 of the last 4 quarters.
The mean historical PE Ratio of Nymox Pharmaceutical Corporation over the last ten years is -8.56. The current -2.86 PE Ratio has changed 3.24% with respect to the historical average. Over the past ten years (40 quarters), NYMX's PE Ratio was at its highest in in the June 2022 quarter at 7.42. The PE Ratio was at its lowest in in the September 2021 quarter at -13.08.
Average
-8.56
Median
-8.50
Minimum
-15.60
Maximum
-2.09
Discovering the peaks and valleys of Nymox Pharmaceutical Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 53.90%
Maximum Annual PE Ratio = -2.09
Minimum Annual Increase = -59.89%
Minimum Annual PE Ratio = -15.60
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.09 | -59.89% |
| 2023 | -5.20 | 19.53% |
| 2022 | -4.35 | -48.83% |
| 2021 | -8.50 | -45.50% |
| 2020 | -15.60 | 35.54% |
| 2019 | -11.51 | 53.90% |
| 2018 | -7.48 | -42.21% |
| 2017 | -12.94 | 37.63% |
The current PE Ratio of Nymox Pharmaceutical Corporation (NYMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.88
5-year avg
-7.15
10-year avg
-8.56
Nymox Pharmaceutical Corporation’s PE Ratio is less than COSCIENS Biopharma Inc. (-0.36), greater than Pieris Pharmaceuticals, Inc. (-5.65), less than PHAXIAM Therapeutics S.A. (-0.02), greater than MEI Pharma, Inc. (-7.82), less than MetaVia Inc. (-1.18), less than AlphaTON Capital Corp. (-0.14), less than Kineta, Inc. (-0.96), less than Traws Pharma, Inc. (-0.82), less than Theriva Biologics, Inc. (-0.04), less than Elevation Oncology, Inc. (-0.45),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.36 | $6.65M | |
| -5.65 | $17.96M | |
| -0.02 | $19.86M | |
| -7.82 | $20.45M | |
| -1.18 | $18.98M | |
| -0.14 | $1.64M | |
| -0.96 | $7.05M | |
| -0.82 | $6.08M | |
| -0.04 | $6.43M | |
| -0.45 | $21.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nymox Pharmaceutical Corporation's PE Ratio?
How is the PE Ratio calculated for Nymox Pharmaceutical Corporation (NYMX)?
What is the highest PE Ratio for Nymox Pharmaceutical Corporation (NYMX)?
What is the 3-year average PE Ratio for Nymox Pharmaceutical Corporation (NYMX)?
What is the 5-year average PE Ratio for Nymox Pharmaceutical Corporation (NYMX)?
How does the current PE Ratio for Nymox Pharmaceutical Corporation (NYMX) compare to its historical average?